trending Market Intelligence /marketintelligence/en/news-insights/trending/t-tmk1lhnxfqwhr4bc3nna2 content
BY CONTINUING TO USE THIS SITE, YOU ARE AGREEING TO OUR USE OF COOKIES. REVIEW OUR
PRIVACY & COOKIE NOTICE
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *

* Required

In this list

Knight Therapeutics to invest up to $2M in Synergy CHC

Shareholder Advocates Say New SEC Policy To Prompt Litigation, Less Transparency

Groups Urge Business Roundtable CEOs To Act On New Corporate Purpose Declaration

State of South Korean OTT Video: Subscription

Global Streaming Media Device Sales Forecast To Flatten In 5 Year Outlook


Knight Therapeutics to invest up to $2M in Synergy CHC

Knight Therapeutics Inc. plans to invest up to $2 million in Synergy CHC Corp.

The company said it would make the investment if Synergy meets certain targets in 2017.

Knight Therapeutics also swapped its existing share purchase warrants and stock options for 7.5 million Synergy shares valued at $2.9 million based on the company's Dec. 23 closing price of 39 cents apiece.

Knight Therapeutics now owns 17.6 million shares of the company, representing a 19.9% stake.